Abhishek Puri (for Info only, not official)


Abhishek Puri

We are collecting authors'profile. As soon as we get, we update it. Please note this is not official profile. The information including photo is collected from web.

| Contact |

| twitter |

| Linkedin |

    Media Object

    Short extract

    ...Novartis had been fighting in the SC to patent a drug used in chronic myeloid leukaemia and other cancerous conditions.The National Cancer Institute, a public body that provides grants to scientists in the US, originally funded the research.It is on record that its innovator had to "persist" with the managers of the erstwhile Ciba-Geigy (which merged with Sandoz to form Novartis), who did not initially show interest, but later it was hailed as a breakthrough drug.Like others, Novartis was just an interface to bring publicly funded university research and to commercialise the molecule after human clinical trials.The stakes are high because of prolonged lead-time from development to marketing.It is near impossible to recoup investments without a protective patent regime.The bulk of innovation in the drug industry has taken place in Europe and the US. ...

    Indian Express on April 15, 2013, 2:45 a.m.